Arizona State Retirement System Reata Pharmaceuticals Inc Transaction History

Arizona State Retirement System

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$79.22 - $105.37 $83,339 - $110,849	-1,052 Reduced 13.46%	6,762 $689,000
Q1 2023 Apr 27, 2023	BUY	$30.85 - $93.17 $7,373 - $22,267	239 Added 3.16%	7,814 $710,000
Q4 2022 Feb 07, 2023	BUY	$22.15 - $42.11 $167,786 - $318,983	7,575 New	7,575 $287,000
Q2 2022 Jul 28, 2022	BUY	$20.71 - $36.5 $393 - $693	19 Added 0.26%	7,250 $220,000
Q1 2022 May 04, 2022	BUY	$24.12 - $39.6 $174,411 - $286,347	7,231 New	7,231 $237,000
Q4 2021 Feb 04, 2022	SELL	$25.61 - $110.96 $186,005 - $805,902	-7,263 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $8,400 - $12,013	84 Added 1.17%	7,263 $731,000
Q2 2021 Aug 02, 2021	BUY	$78.27 - $151.29 $3,443 - $6,656	44 Added 0.62%	7,179 $1.02 Million
Q1 2021 May 06, 2021	BUY	$94.25 - $132.81 $8,953 - $12,616	95 Added 1.35%	7,135 $711,000
Q4 2020 Jan 28, 2021	SELL	$102.03 - $184.62 $18,773 - $33,970	-184 Reduced 2.55%	7,040 $870,000
Q3 2020 Nov 05, 2020	BUY	$93.53 - $163.34 $174,807 - $305,282	1,869 Added 34.9%	7,224 $704,000
Q2 2020 Aug 04, 2020	BUY	$126.3 - $176.56 $31,953 - $44,669	253 Added 4.96%	5,355 $835,000
Q1 2020 May 05, 2020	BUY	$124.16 - $247.74 $633,464 - $1.26 Million	5,102 New	5,102 $736,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.